California Cancer Reporting System Standards, Volume III

Eureka Edits

IF822:  CS Lymph Nodes, SSF3, Nodes Eval, MelanomaSkin (CS)

Edit Sets:

California Hospital Transmit

Eureka Admission Level

Eureka Tumor Level

Fields:

Primary Site [NAACCR #400]

Histologic Type ICD-O-3 [NAACCR #522]

Behavior Code ICD-O-3 [NAACCR #523]

CS Lymph Nodes [NAACCR #2830]

CS Site-Specific Factor 3 [NAACCR #2900]

CS Lymph Nodes Eval [NAACCR #2840]

CS Site-Specific Factor 25 [NAACCR #2879]

Message:

IF 822:  Melanoma of skin schema:  If CS Lymph Nodes [value], CS Site-Specific Factor 3 [value], then CS Lymph Node Eval cannot be [value].

Specification:

The purpose of this edit is to compare CS Lymph Nodes, CS Site-Specific 3, and CS Reg Nodes Eval for cases coded using the Melanoma of Skin Schema.

This edit is skipped if any of the following conditions are true:

1. 1. CS Lymph Nodes is empty

   2. CS Site-Specific Factor 3 is empty or = 988

   3. Behavior Code ICD-O-3 = 0 (benign) or 1 (borderline)

   4. CS schema is invalid

This edit first determines the correct CS schema by doing a function call to the CS Dynamic Link Library (dll). The function call passes Primary Site, Histologic Type ICD-O-3, and CS Site-Specific Factor25 (schema discriminator) to the dll and the CS schema name is returned.

The following logic applies from NAACCR 12.2 and CSv02.04 forward. (To be implemented in Eureka in approximately May 2012.)

If schema is MelanomaSkin:

1. • If CS Site-Specific Factor 3 = 000 or 005 (see definitions below), then CS Lymph Nodes must not = 121 or 128 (codes that indicate case evaluated clinically)

   • If CS Lymph Nodes = 121 or 128 (codes that indicate case evaluated clinically), then CS Lymph Nodes Eval must = 0, 1, 5 (codes that indicate case does not meet criteria for AJCC pathological stage) or 9 (unknown)

   • If CS Lymph Nodes = 122, 123, 124, 152, 153, or 158 (codes that indicate case was evaluated pathologically), then CS Lymph Nodes Eval must = 2, 3, 6, 8 (codes that indicate case meets requirement for AJCC pathologic staging) or 9 (unknown)

   • If CS Site-Specific Factor 3 = 020, 043, 045, 048, 050, 100, or 150 (codes indicating 'clinically apparent'), then CS Lymph Nodes Eval must not = 8 (diagnosed at autopsy)

The following logic applies prior to NAACCR 12.2 and CSv02.04. (Will become obsolete in approximately May 2012)

If schema is MelanomaSkin schema:

1. • If regional lymph nodes are negative, clinical status of lymph node mets (coded in site-specific factor 3) must also be negative, per the note for the CS Site-Specific Factor 3 field in the CS manual. Logic: If CS Lymph Nodes = 000, 130, 140, 150 or 154. CS Site-Specific Factor 3 must = 000.

   • If regional lymph nodes are positive and site-specific factor 3 is coded as nodes clinically not apparent, regional nodes eval must not indicate clinical evaluation of nodes. Logic:  If CS Lymph Nodes = 100, 120, 170, 180, 200, 220, 800 and if CS Site-Specific Factor 3 = 010, then CS Lymph Nodes Eval must not = 0.

   • If regional lymph nodes are positive and site-specific factor 3 is coded as nodes clinically apparent, regional nodes eval must not indicate nodes diagnosed only at autopsy. Logic:  If CS Lymph Nodes = 100, 120, 170, 180, 200, 220, 800 and if CS Site-Specific Factor 3 = 020, then CS Lymph Nodes Eval must not = 8.

   • If regional lymph nodes are unknown, clinical status of lymph node mets (coded in site-specific factor 3) must also be unknown. Logic: If CS Lymph Nodes = 999, CS Site-Specific Factor 3 must = 999.

**************************************************************

CS Site-Specific Factor 3 definitions for codes 000 and 005:

000 = OBSOLETE DATA RETAINED V0204

No lymph node metastasis

005 = Clinically negative lymph node metastasis

AND

No pathologic examination performed

Or unknown if pathologic examination performed

Or nodes negative on pathologic examination

*************************************************************

Historical Changes

In the SEER*Edits software, this edit is IF216.